Research and experimental verification of the molecular mechanism of berberine in improving premature ovarian failure based on network pharmacology

References

• Goswami D, Conway GS. Premature ovarian failure. Hum Reprod Update. 2005;11(4):391–410.
   PubMed Web of Science ®Google Scholar
• LJTNEjom N. Clinical practice. Primary ovarian insufficiency. 2009;360(6):606–614.
   Google Scholar
• Trabert B, Wentzensen N, Yang HP, et al. Ovarian cancer and menopausal hormone therapy in the NIH-AARP diet and health study. Br J Cancer. 2012;107(7):1181–1187.
   PubMed Web of Science ®Google Scholar
• Trabert B, Wentzensen N, Yang HP, et al. Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk? Int J Cancer. 2013;132(2):417–426.
   PubMed Web of Science ®Google Scholar
• Kuang H, Duan Y, Li D, et al. The role of serum inflammatory cytokines and berberine in the insulin signaling pathway among women with polycystic ovary syndrome. PLoS One. 2020;15(8):e0235404.
   PubMed Web of Science ®Google Scholar
• Zhang N, Liu X, Zhuang L, et al. Berberine decreases insulin resistance in a PCOS rats by improving GLUT4: dual regulation of the PI3K/AKT and MAPK pathways. Regul Toxicol Pharmacol. 2020;110:104544.
   PubMed Web of Science ®Google Scholar
• Liu M, Qiu Y, Xue Z, et al. Small extracellular vesicles derived from embryonic stem cells restore ovarian function of premature ovarian failure through PI3K/AKT signaling pathway. Stem Cell Res Ther. 2020;11(1):3.
   PubMed Web of Science ®Google Scholar
• Luo TT, Lu Y, Yan SK, et al. Network Pharmacology in Research of Chinese Medicine Formula: methodology, Application and Prospective. Chin J Integr Med. 2020;26(1):72–80.
   PubMed Web of Science ®Google Scholar
• Ru J, Li P, Wang J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6(1):13.
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Santos A, von Mering C, et al. STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data. Nucleic Acids Res. 2016;44(D1):D380–384.
   PubMed Web of Science ®Google Scholar
• Stelzer G, Rosen N, Plaschkes I, et al. The GeneCards Suite: from Gene Data Mining to Disease Genome Sequence Analyses. Curr Protoc Bioinformatics. 2016;54(1):1 30 31–31 30 33.
   Google Scholar
• Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607–D613.
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504.
   PubMed Web of Science ®Google Scholar
• The Gene Ontology C. The Gene Ontology Resource: 20 years and still GOing strong. Nucleic Acids Res. 2019;47(D1):D330–D338.
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Furumichi M, Sato Y, et al. KEGG: integrating viruses and cellular organisms. Nucleic Acids Res. 2021;49(D1):D545–D551.
   Web of Science ®Google Scholar
• Meirow D, Lewis H, Nugent D, et al. Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: clinical importance and proposed accurate investigative tool. Hum Reprod. 1999;14(7):1903–1907.
   PubMed Web of Science ®Google Scholar
• Marcondes FK, Bianchi FJ, Tanno AP. Determination of the estrous cycle phases of rats: some helpful considerations. Braz J Biol. 2002;62(4A):609–614.
   PubMedGoogle Scholar
• Hornbeck PV. Enzyme-Linked Immunosorbent Assays. Curr Protoc Immunol. 2015;110(1):2 1 1–2 1 23.
   PubMedGoogle Scholar
• Hirano S. Western blot analysis. Methods Mol Biol. 2012;926:87–97.
   PubMedGoogle Scholar
• Jozefczuk J, Adjaye J. Quantitative real-time PCR-based analysis of gene expression. Methods Enzymol. 2011;500:99–109.
   PubMed Web of Science ®Google Scholar
• Zachow R, Uzumcu M. The methoxychlor metabolite, 2,2-bis-(p-hydroxyphenyl)-1,1,1-trichloroethane, inhibits steroidogenesis in rat ovarian granulosa cells in vitro. Reprod Toxicol. 2006;22(4):659–665.
   PubMed Web of Science ®Google Scholar
• Odell ID, Cook D. Immunofluorescence techniques. J Invest Dermatol. 2013;133(1):e4.
   PubMed Web of Science ®Google Scholar
• Qin C, Zhang Q, Wu G. RANBP9 suppresses tumor proliferation in colorectal cancer. Oncol Lett. 2019;17(5):4409–4416.
   PubMed Web of Science ®Google Scholar
• Fu X, He Y, Wang X, et al. Overexpression of miR-21 in stem cells improves ovarian structure and function in rats with chemotherapy-induced ovarian damage by targeting PDCD4 and PTEN to inhibit granulosa cell apoptosis. Stem Cell Res Ther. 2017;8(1):187.
   PubMed Web of Science ®Google Scholar
• Burgering BM, Kops GJ. Cell cycle and death control: long live Forkheads. Trends Biochem Sci. 2002;27(7):352–360.
   PubMed Web of Science ®Google Scholar
• Cai L, Zong DK, Tong GQ, et al. Apoptotic mechanism of premature ovarian failure and rescue effect of Traditional Chinese Medicine: a review. J Tradit Chin Med. 2021;41(3):492–498.
   PubMed Web of Science ®Google Scholar
• Ishise S, Okuda K, Kumazawa T, et al. Proceedings: rupture of Valsalva’s sinus –a case study. Jpn Circ J. 1975;39(6):739.
   PubMedGoogle Scholar
• Yang R, Xu S, Zhao Z, et al. Fas ligand expression and mediated activation of an apoptosis program in bovine follicular granulosa cells. Gene. 2012;493(1):148–154.
   PubMed Web of Science ®Google Scholar
• Jang H, Lee OH, Lee Y, et al. Melatonin prevents cisplatin-induced primordial follicle loss via suppression of PTEN/AKT/FOXO3a pathway activation in the mouse ovary. J Pineal Res. 2016;60(3):336–347.
   PubMed Web of Science ®Google Scholar
• Jamil Z, Fatima SS, Ahmed K, et al. Anti-Mullerian Hormone: above and Beyond Conventional Ovarian Reserve Markers. Dis Markers. 2016;2016:5246217.
   PubMed Web of Science ®Google Scholar
• Weghofer A, Schnepf S, Barad D, et al. The impact of luteinizing hormone in assisted reproduction: a review. Curr Opin Obstet Gynecol. 2007;19(3):253–257.
   PubMed Web of Science ®Google Scholar
• Visser JA, Schipper I, Laven JS, et al. Anti-Mullerian hormone: an ovarian reserve marker in primary ovarian insufficiency. Nat Rev Endocrinol. 2012;8(6):331–341.
   PubMed Web of Science ®Google Scholar
• Moolhuijsen LME, Visser JA. Anti-Mullerian Hormone and Ovarian Reserve: update on Assessing Ovarian Function. J Clin Endocrinol Metab. 2020;105(11):3361–3373.
   PubMed Web of Science ®Google Scholar
• Kalich-Philosoph L, Roness H, Carmely A, et al. Cyclophosphamide triggers follicle activation and “burnout”; AS101 prevents follicle loss and preserves fertility. Sci Transl Med. 2013;5(185):185ra162.
   Web of Science ®Google Scholar
• Yang M, Lin L, Sha C, et al. Bone marrow mesenchymal stem cell-derived exosomal miR-144-5p improves rat ovarian function after chemotherapy-induced ovarian failure by targeting PTEN. Lab Invest. 2020;100(3):342–352.
   PubMed Web of Science ®Google Scholar
• Reddy P, Liu L, Adhikari D, et al. Oocyte-specific deletion of Pten causes premature activation of the primordial follicle pool. Science. 2008;319(5863):611–613.
   PubMed Web of Science ®Google Scholar
• Adhikari D, Liu K. Molecular mechanisms underlying the activation of mammalian primordial follicles. Endocr Rev. 2009;30(5):438–464.
   PubMed Web of Science ®Google Scholar
• Lv Y, Cao RC, Liu HB, et al. Single-Oocyte Gene Expression Suggests That Curcumin Can Protect the Ovarian Reserve by Regulating the PTEN-AKT-FOXO3a Pathway. Int J Mol Sci. 2021;22(12):6570.
   PubMed Web of Science ®Google Scholar
• Hu Y, Yuan DZ, Wu Y, et al. Bisphenol A Initiates Excessive Premature Activation of Primordial Follicles in Mouse Ovaries via the PTEN Signaling Pathway. Reprod Sci. 2018;25(4):609–620.
   PubMed Web of Science ®Google Scholar
• Fan HY, Liu Z, Cahill N, et al. Targeted disruption of Pten in ovarian granulosa cells enhances ovulation and extends the life span of luteal cells. Mol Endocrinol. 2008;22(9):2128–2140.
   PubMedGoogle Scholar
• Kallen A, Polotsky AJ, Johnson J. Untapped Reserves: controlling Primordial Follicle Growth Activation. Trends Mol Med. 2018;24(3):319–331.
   PubMed Web of Science ®Google Scholar
• Wesevich V, Kellen AN, Pal L. Recent advances in understanding primary ovarian insufficiency. F1000Res. 2020;9:1101.
   Google Scholar
• Monniaux D, Clement F, Dalbies-Tran R, et al. The ovarian reserve of primordial follicles and the dynamic reserve of antral growing follicles: what is the link? Biol Reprod. 2014;90(4):85.
   PubMed Web of Science ®Google Scholar
• Park Y, Maizels ET, Feiger ZJ, et al. Induction of cyclin D2 in rat granulosa cells requires FSH-dependent relief from FOXO1 repression coupled with positive signals from Smad. J Biol Chem. 2005;280(10):9135–9148.
   PubMed Web of Science ®Google Scholar
• Yue D, Sun X. Idelalisib promotes Bim-dependent apoptosis through AKT/FoxO3a in hepatocellular carcinoma. Cell Death Dis. 2018;9(10):935.
   PubMed Web of Science ®Google Scholar
• Shukla S, Saxena S, Singh BK, et al. BH3-only protein BIM: an emerging target in chemotherapy. Eur J Cell Biol. 2017;96(8):728–738.
   PubMed Web of Science ®Google Scholar
• Stahl M, Dijkers PF, Kops GJ, et al. The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2. J Immunol. 2002;168(10):5024–5031.
   PubMed Web of Science ®Google Scholar
• Harada H, Grant S. Targeting the regulatory machinery of BIM for cancer therapy. Crit Rev Eukaryot Gene Expr. 2012;22(2):117–129.
   PubMed Web of Science ®Google Scholar